{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:10:42Z","timestamp":1792789842515,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03889-3","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T11:02:28Z","timestamp":1703761348000},"page":"2001-2010","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation on chronic hemodialysis: a meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4805-0931","authenticated-orcid":false,"given":"Denilsa D. P.","family":"Navalha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-3866","authenticated-orcid":false,"given":"Nicole","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-6179","authenticated-orcid":false,"given":"Alleh","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5842-9007","authenticated-orcid":false,"given":"Mariana","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3838-5765","authenticated-orcid":false,"given":"Alice D.","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3203-0509","authenticated-orcid":false,"given":"Rafael Oliva Morgado","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-1162","authenticated-orcid":false,"given":"Eric","family":"Pasqualotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5047-4023","authenticated-orcid":false,"given":"Caroline Serafim","family":"Dagostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-4075","authenticated-orcid":false,"given":"Luis Cl\u00e1udio Santos","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5847-0708","authenticated-orcid":false,"given":"Gilson C.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"issue":"8","key":"3889_CR1","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI et al (2023) Heart disease and stroke statistics\u20142023 update: a report from the american heart association. Circulation 147(8):e93\u2013e621. https:\/\/doi.org\/10.1161\/CIR.0000000000001123","journal-title":"Circulation"},{"issue":"10","key":"3889_CR2","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/CIRCRESAHA.121.318186","volume":"128","author":"JN Njoroge","year":"2021","unstructured":"Njoroge JN, Teerlink JR (2021) Pathophysiology and therapeutic approaches to acute decompensated heart failure. Circ Res 128(10):1468\u20131486. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318186","journal-title":"Circ Res"},{"issue":"6","key":"3889_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011721","volume":"8","author":"SB Brusca","year":"2019","unstructured":"Brusca SB, Barnett C, Barnhart BJ et al (2019) Role of critical care medicine training in the cardiovascular intensive care unit: survey responses from dual certified critical care cardiologists. J Am Heart Assoc 8(6):e011721. https:\/\/doi.org\/10.1161\/JAHA.118.011721","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3889_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/0886022X.2020.1801467","volume":"42","author":"SD Baek","year":"2020","unstructured":"Baek SD, Jeung S, Kang JY, Jeon KH (2020) Dialysis-specific factors and incident atrial fibrillation in hemodialysis patients. Ren Fail 42(1):785\u2013791. https:\/\/doi.org\/10.1080\/0886022X.2020.1801467","journal-title":"Ren Fail"},{"issue":"5","key":"3889_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.14503\/THIJ-13-3466","volume":"41","author":"R Galea","year":"2014","unstructured":"Galea R, Cardillo MT, Caroli A et al (2014) Inflammation and C-reactive protein in atrial fibrillation: cause or effect? Tex Heart Inst J 41(5):461\u2013468. https:\/\/doi.org\/10.14503\/THIJ-13-3466","journal-title":"Tex Heart Inst J"},{"issue":"2","key":"3889_CR6","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4103\/1319-2442.256845","volume":"30","author":"P Avramovski","year":"2019","unstructured":"Avramovski P, Avramovska M, Sotiroski K, Sikole A (2019) Acute-phase proteins as promoters of abdominal aortic calcification in chronic dialysis patients. Saudi J Kidney Dis Transpl 30(2):376\u2013386. https:\/\/doi.org\/10.4103\/1319-2442.256845","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"3889_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003786","author":"WT O\u2019Neal","year":"2015","unstructured":"O\u2019Neal WT, Efird JT, Qureshi WT et al (2015) Coronary artery calcium progression and atrial fibrillation: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.003786","journal-title":"Circ Cardiovasc Imaging"},{"issue":"12","key":"3889_CR8","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/europace\/euq387","volume":"12","author":"F Yang","year":"2010","unstructured":"Yang F, Chou D, Schweitzer P, Hanon S (2010) Warfarin in haemodialysis patients with atrial fibrillation: what benefit? EP Europace 12(12):1666\u20131672. https:\/\/doi.org\/10.1093\/europace\/euq387","journal-title":"EP Europace"},{"issue":"15","key":"3889_CR9","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/CIRCULATIONAHA.118.037091","volume":"138","author":"SU Nigwekar","year":"2018","unstructured":"Nigwekar SU, Thadhani R (2018) Long-term anticoagulation for patients receiving dialysis tilting the benefit-to-risk ratio? Circulation 138(15):1530\u20131533. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.037091","journal-title":"Circulation"},{"issue":"7","key":"3889_CR10","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.clinthera.2017.05.358","volume":"39","author":"AR Almutairi","year":"2017","unstructured":"Almutairi AR, Zhou L, Gellad WF et al (2017) Effectiveness and safety of non-vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses. Clin Ther 39(7):1456-1478.e36. https:\/\/doi.org\/10.1016\/j.clinthera.2017.05.358","journal-title":"Clin Ther"},{"key":"3889_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18094443","author":"P Manckoundia","year":"2021","unstructured":"Manckoundia P, Nuemi G, Hacquin A et al (2021) Direct oral anticoagulants versus Vitamin K antagonists in patients aged 80 years and older. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph18094443","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"3889_CR12","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1681\/ASN.2020111566","volume":"32","author":"AS de Vriese","year":"2021","unstructured":"de Vriese AS, Caluw\u00e9 R, van der Meersch H, de Boeck K, de Bacquer D (2021) Safety and efficacy of Vitamin K antagonists versus rivaroxaban in hemodialysis patients with atrial fibrillation: A multicenter randomized controlled trial. J Am Soc Nephrol 32(6):1474\u20131483. https:\/\/doi.org\/10.1681\/ASN.2020111566","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3889_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10557-021-07144-8","volume":"35","author":"C Chen","year":"2021","unstructured":"Chen C, Cao Y, Zheng Y et al (2021) Effect of rivaroxaban or apixaban in atrial fibrillation patients with stage 4\u20135 chronic kidney disease or on dialysis. Cardiovasc Drugs Ther 35(2):273\u2013281. https:\/\/doi.org\/10.1007\/s10557-021-07144-8","journal-title":"Cardiovasc Drugs Ther"},{"issue":"4","key":"3889_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40261-021-01016-7","volume":"41","author":"HY Chen","year":"2021","unstructured":"Chen HY, Ou SH, Huang CW et al (2021) Efficacy and safety of direct oral anticoagulants vs warfarin in patients with chronic kidney disease and dialysis patients: a systematic review and meta-analysis. Clin Drug Invest 41(4):341\u2013351. https:\/\/doi.org\/10.1007\/s40261-021-01016-7","journal-title":"Clin Drug Invest"},{"issue":"5","key":"3889_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1053\/j.ajkd.2021.02.328","volume":"78","author":"X Su","year":"2021","unstructured":"Su X, Yan B, Wang L, Lv J, Cheng H, Chen Y (2021) Oral anticoagulant agents in patients with atrial fibrillation and CKD: a systematic review and pairwise network meta-analysis. Am J Kidney Dis 78(5):678-689.e1. https:\/\/doi.org\/10.1053\/j.ajkd.2021.02.328","journal-title":"Am J Kidney Dis"},{"key":"3889_CR16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1681\/ASN.20213210S1728c","volume":"32","author":"J Ha","year":"2021","unstructured":"Ha J, Gallagher MP, Jun M (2021) The comparative effectiveness and safety of rivaroxaban and warfarin initiation in adults with atrial fibrillation (AF) by egfr category. J Am Soc Nephrol 32:728","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"3889_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/ndt\/gfy031","volume":"34","author":"J Feldberg","year":"2019","unstructured":"Feldberg J, Patel P, Farrell A et al (2019) A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation. Nephrol Dial Transplant 34(2):265\u2013277. https:\/\/doi.org\/10.1093\/ndt\/gfy031","journal-title":"Nephrol Dial Transplant"},{"key":"3889_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"3889_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"issue":"4","key":"3889_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/CIRCULATIONAHA.122.062779","volume":"147","author":"H Reinecke","year":"2023","unstructured":"Reinecke H, Engelbertz C, Bauersachs R et al (2023) A randomized controlled trial comparing apixaban with the Vitamin K antagonist phenprocoumon in patients on chronic hemodialysis: The AXADIA-AFNET 8 Study. Circulation 147(4):296\u2013309. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062779","journal-title":"Circulation"},{"issue":"23","key":"3889_CR21","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.121.054990","volume":"146","author":"SD Pokorney","year":"2022","unstructured":"Pokorney SD, Chertow GM, Al-Khalidi HR et al (2022) Apixaban for patients with atrial fibrillation on hemodialysis: a multicenter randomized controlled trial. Circulation 146(23):1735\u20131745. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054990","journal-title":"Circulation"},{"key":"3889_CR22","doi-asserted-by":"publisher","unstructured":"Schulman S, Kearon C, The Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. Journal of Thrombosis and Haemostasis. 2005;3(4):692\u2013694. doi:https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"issue":"12","key":"3889_CR23","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ki.2009.477","volume":"77","author":"V Wizemann","year":"2010","unstructured":"Wizemann V, Tong L, Satayathum S et al (2010) Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 77(12):1098\u20131106. https:\/\/doi.org\/10.1038\/ki.2009.477","journal-title":"Kidney Int"},{"issue":"8","key":"3889_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/clc.23196","volume":"42","author":"V Aursulesei","year":"2019","unstructured":"Aursulesei V, Costache II (2019) Anticoagulation in chronic kidney disease: from guidelines to clinical practice. Clin Cardiol 42(8):774\u2013782. https:\/\/doi.org\/10.1002\/clc.23196","journal-title":"Clin Cardiol"},{"key":"3889_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ahj.2016.09.016","volume":"184","author":"H Van Der Meersch","year":"2017","unstructured":"Van Der Meersch H, De Bacquer D, De Vriese AS (2017) Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis. Am Heart J 184:37\u201346. https:\/\/doi.org\/10.1016\/j.ahj.2016.09.016","journal-title":"Am Heart J"},{"issue":"4","key":"3889_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2175","volume":"3","author":"MS Randhawa","year":"2020","unstructured":"Randhawa MS, Vishwanath R, Rai MP et al (2020) Association between use of warfarin for atrial fibrillation and outcomes among patients with end-stage renal disease: a systematic review and meta-analysis. JAMA Netw Open 3(4):e202175. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2175","journal-title":"JAMA Netw Open"},{"issue":"4","key":"3889_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000525387","volume":"12","author":"L Di Lullo","year":"2022","unstructured":"Di Lullo L, Mariani MV, Ronco C et al (2022) Atrial fibrillation and anticoagulant treatment in end-stage renal disease patients: where do we stand? CardioRenal Med 12(4):131\u2013140. https:\/\/doi.org\/10.1159\/000525387","journal-title":"CardioRenal Med"},{"issue":"5","key":"3889_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40620-018-0501-7","volume":"31","author":"L Di Lullo","year":"2018","unstructured":"Di Lullo L, Tripepi G, Ronco C et al (2018) Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data. J Nephrol 31(5):751\u2013756. https:\/\/doi.org\/10.1007\/s40620-018-0501-7","journal-title":"J Nephrol"},{"issue":"1","key":"3889_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/heartjnl-2019-314898","volume":"106","author":"S Jame","year":"2020","unstructured":"Jame S, Barnes G (2020) Stroke and thromboembolism prevention in atrial fibrillation. Heart 106(1):10\u201317. https:\/\/doi.org\/10.1136\/heartjnl-2019-314898","journal-title":"Heart"},{"issue":"22","key":"3889_CR30","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1093\/eurheartj\/ehs274","volume":"33","author":"SH Hohnloser","year":"2012","unstructured":"Hohnloser SH, Hijazi Z, Thomas L et al (2012) Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. Eur Heart J 33(22):2821\u20132830. https:\/\/doi.org\/10.1093\/eurheartj\/ehs274","journal-title":"Eur Heart J"},{"issue":"1","key":"3889_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.116.021890","volume":"134","author":"CB Fordyce","year":"2016","unstructured":"Fordyce CB, Hellkamp AS, Lokhnygina Y et al (2016) On-treatment outcomes in patients with worsening renal function with rivaroxaban compared with warfarin. Circulation 134(1):37\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.021890","journal-title":"Circulation"},{"issue":"9","key":"3889_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.113.003628","volume":"129","author":"Z Hijazi","year":"2014","unstructured":"Hijazi Z, Hohnloser SH, Oldgren J et al (2014) Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis. Circulation 129(9):961\u2013970. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003628","journal-title":"Circulation"},{"issue":"1","key":"3889_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.116.022361","volume":"134","author":"EA Bohula","year":"2016","unstructured":"Bohula EA, Giugliano RP, Ruff CT et al (2016) Impact of renal function on outcomes with Edoxaban in the ENGAGE AF-TIMI 48 trial. Circulation 134(1):24\u201336. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022361","journal-title":"Circulation"},{"issue":"11","key":"3889_CR34","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1093\/ndt\/gfab060","volume":"37","author":"AS De Vriese","year":"2022","unstructured":"De Vriese AS, Heine G (2022) Anticoagulation management in haemodialysis patients with atrial fibrillation: evidence and opinion. Nephrol Dial Transplant 37(11):2072\u20132079. https:\/\/doi.org\/10.1093\/ndt\/gfab060","journal-title":"Nephrol Dial Transplant"},{"key":"3889_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062752","author":"J Harrington","year":"2023","unstructured":"Harrington J, Carnicelli AP, Hua K et al (2023) Direct oral anticoagulants versus warfarin across the spectrum of kidney function: patient-level network meta-analyses From COMBINE AF. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062752","journal-title":"Circulation"},{"key":"3889_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.847286","author":"S Elfar","year":"2022","unstructured":"Elfar S, Elzeiny SM, Ismail H, Makkeyah Y, Ibrahim M (2022) Direct oral anticoagulants vs. warfarin in hemodialysis patients with atrial fibrillation: a systematic review and meta-analysis. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2022.847286","journal-title":"Front Cardiovasc Med."},{"issue":"5","key":"3889_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10557-020-07108-4","volume":"35","author":"LC See","year":"2021","unstructured":"See LC, Lee HF, Chao TF et al (2021) Effectiveness and safety of direct oral anticoagulants in an Asian population with atrial fibrillation undergoing dialysis: a population-based cohort study and meta-analysis. Cardiovasc Drugs Ther 35(5):975\u2013986. https:\/\/doi.org\/10.1007\/s10557-020-07108-4","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03889-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03889-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03889-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T23:42:53Z","timestamp":1730936573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03889-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["3889"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03889-3","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors report no relationships that could be construed as a conflict of interest. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}